Future research exploring the dose-effect association between ApoE ɛ 4 genotypes and amyloid neuropathology of AD, or in conjunction with other markers can help to better understand the pathophysiological role of ApoE ɛ 4 and improve the diagnostic accuracy in AD. The gene discussed is APOE; the disease is Alzheimer disease.